Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2020-03-02 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
COMPLETION OF ISSUE OF UNLISTED WARRANTS UNDER SPECIFIC MANDATE
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the completion of the issue of unlisted warrants under a specific mandate. It details the terms of the warrant issue, the effect on shareholding structure, and references previous announcements and circulars related to the warrant issuance. The document does not contain financial statements or detailed financial performance data but rather focuses on the capital raising activity through warrants issuance. It is not a full financial report, earnings release, or management discussion. The content fits the category of a Capital/Financing Update as it provides information on fundraising and changes in capital structure through the issuance of warrants.
2020-03-02 English
DELAY IN DESPATCH OF CIRCULAR
Report Publication Announcement Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding a delay in the despatch of a circular related to a connected transaction under the GEM Listing Rules. It references the original announcement and explains the postponement of the circular's despatch date. The document is short (3041 characters) and does not contain any financial statements, detailed financial data, or the circular itself. It is an announcement about the timing of a report (the circular), not the report itself. Therefore, according to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2020-02-28 English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE
Capital/Financing Update Classification · 90% confidence The document is a voluntary announcement by Sinopharm Tech Holdings Limited regarding a business update about entering into a purchase order contract for production line equipment. It is not a financial report, earnings release, or regulatory filing. The document is relatively short (4481 characters) and provides an update on business operations rather than detailed financial data or formal report content. It does not announce voting results, management changes, or legal proceedings. The content fits best as a Capital/Financing Update since it discusses procurement of production equipment which impacts the company's operational capacity and strategic deployment. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-02-20 English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sinopharm Tech Holdings Limited regarding a business update about entering into a purchase order contract for production lines and plans for capital injection into a joint venture company. It provides details on the business development and operational plans but does not contain financial statements, audit information, or regulatory certifications. The document is not a full financial report, earnings release, or management discussion. It is a corporate announcement informing shareholders and investors about a business transaction and update. The length is about 6,486 characters, which is relatively short and typical for an announcement rather than a full report. Therefore, it fits best under the category of a Regulatory Filing (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other specific categories.
2020-02-19 English
VOLUNTARY ANNOUNCEMENT - IN RELATION TO FORMATION OF JOINT VENTURE
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by Sinopharm Tech Holdings Limited regarding the formation of a joint venture. It details the terms of the joint venture contract, shareholding structure, business purpose, and strategic rationale. There is no financial data, no regulatory certification, no voting results, no management or board changes, and no earnings or annual report content. The document is an announcement of a business development event, specifically a joint venture formation, which fits the category of Capital/Financing Update (CAP) as it relates to changes in the company's capital structure and business operations through a joint venture. The document length is about 10,787 characters, which is substantive and not a mere report publication announcement. Therefore, the best classification is CAP with high confidence.
2020-02-18 English
VOLUNTARY ANNOUNCEMENT - IN RELATION TO A STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH ZHUHAI HUAFA GROUP CO. LTD.
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sinopharm Tech Holdings Limited regarding the signing of a strategic cooperation framework agreement with Zhuhai Huafa Group Co. Ltd. It details the scope and content of the cooperation, reasons and benefits, and background information about the parties involved. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is an announcement of a business development and strategic partnership rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a regulatory filing or certification. The document is a voluntary business update announcement informing shareholders and investors about a strategic cooperation agreement. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2020-02-17 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.